Abstract:Linear aromatic N-tricyclic compounds with promising antiviral activity and minimal cytotoxicity were prepared and analyzed in the last years. Specifically, the pyrido[2,3-g]quinoxalinone nucleus was found endowed with high potency against several pathogenic RNA viruses as etiological agents of important veterinary and human pathologies. Following our research program on new antiviral agents we have designed, synthesized and assayed new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives. Lead compounds 1-4 were further modified to enhance their antiviral activity and reduce their cytotoxicity. Thus, different substituents were introduced on N atom at position 1 or the O atom at position 2 of the leads; contextually, several groups were inserted on the nitrogen atom at position 7 of diaminoquinoline intermediates. Title compounds were tested in cell-based assays for cytotoxicity and antiviral activity against RNA virus families containing single-stranded (either positive-sense (ssRNA+) or negative-sense (ssRNA-)), and double-stranded genomes (dsRNA), and against two representatives of DNA virus families. Some derivatives emerged as potential leads for further development as antiviral agents against some viruses of public health significance, such as RSV, Reo, BVDV and HCV. Particularly, compounds 4, 11b, 11c, 13c, 15a, 18 and 21 resulted active against BVDV at concentrations ranging from 1.3 to 5 μM. Compound 21 was also evaluated for its activity on the BVDV RdRp. Compound 4 was also tested as potential anti-HCV compound in a subgenomic replication assay. Molecular simulation results provided a molecular rationale for the anti-BVDV activity of these compounds.

Synthesis, Characterization, and Biological Evaluation of Some Novel Quinoxaline Derivatives as Antiviral Agents

Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives

Efficient Synthesis and Docking Studies of Novel Benzothiazole-Based Pyrimidinesulfonamide Scaffolds as New Antiviral Agents and Hsp90α Inhibitors

First Discovery of Novel 3-Hydroxy-quinazoline-2,4(1h,3h)-diones As Specific Anti-Vaccinia and Adenovirus Agents Via ‘privileged Scaffold’ Refining Approach

Design, synthesis, and antiviral activities evaluation of novel quinazoline derivatives containing sulfonamide moiety

Synthesis and Biological Evaluation of Novel Anti-Hepatitis C Virus (HCV) Agents: 2-Hydroxylphenethyl Sulfanyl-Oxopyrimidines

Synthesis and Anti-HBV Activity of Novel Dihydropyrimidine Analogs

Design, Synthesis, Molecular Modeling Studies and Biological Evaluation of N'-Arylidene-6-(benzyloxy)-4-oxo-1,4-dihydroquinoline-3-carbohydrazide Derivatives as Novel Anti-HCV Agents

Synthesis and Antiviral Activity of a Series of Novel Quinoline Derivatives As Anti-Rsv or Anti-Iav Agents

Synthesis and antiviral bioactivities of 2-aryl- or 2-methyl-3-(substituted- benzalamino)-4(3H)-quinazolinone derivatives.

Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors

Design, synthesis and antiviral activity of novel quinazolinones.

Design, Synthesis, and Antiviral Properties of 2-Aryl-1h-benzimidazole-4-carboxamide Derivatives

Structure–activity relationship studies on quinoxalin-2(1 H )-one derivatives containing thiazol-2-amine against hepatitis C virus leading to the discovery of BH6870

Synthesis, Antiviral Activity, 3D-QSAR, and Interaction Mechanisms Study of Novel Malonate Derivatives Containing Quinazolin-4(3H)-one Moiety.

Design, Synthesis, and Antiviral and Fungicidal Activities of 4-Oxo-4h-quinolin-1-yl Acylhydrazone Derivatives

Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives Bearing A Heterocyclic Ring at 4/5 Position

Synthesis and antiviral bioactivity of novel 3-((2-((1E,4E)-3-oxo-5-arylpenta-1,4-dien-1-yl)phenoxy)methyl)-4(3H)-quinazolinone derivatives.

Synthesis and Anti-Hepatitis B Virus Evaluation of Novel Ethyl 6-Hydroxyquinoline-3-carboxylates in Vitro

Synthesis and Biological Evaluation of Triazolo-pyrimidine Derivatives As Novel Inhibitors of Hepatitis B Virus Surface Antigen (hbsag) Secretion

Synthesis, antiviral activity against wild-type SARS-CoV-2 and molecular docking studies of new aryl(1,2-dithiolo[3,4-c]quinolin-1-ylidene)amines